aristolochene has been researched along with Sick Building Syndrome in 1 studies
*Sick Building Syndrome: A group of symptoms that are two- to three-fold more common in those who work in large, energy-efficient buildings, associated with an increased frequency of headaches, lethargy, and dry skin. Clinical manifestations include hypersensitivity pneumonitis (ALVEOLITIS, EXTRINSIC ALLERGIC); allergic rhinitis (RHINITIS, ALLERGIC, PERENNIAL); ASTHMA; infections, skin eruptions, and mucous membrane irritation syndromes. Current usage tends to be less restrictive with regard to the type of building and delineation of complaints. (From Segen, Dictionary of Modern Medicine, 1992) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, A; De Kimpe, N; De Saeger, S; Moretti, A; Polizzi, V; Van Peteghem, C | 1 |
1 other study(ies) available for aristolochene and Sick Building Syndrome
| Article | Year |
|---|---|
Influence of various growth parameters on fungal growth and volatile metabolite production by indoor molds.
Topics: Analysis of Variance; Camphanes; Gas Chromatography-Mass Spectrometry; Housing; Humans; Humidity; Ketones; Mitosporic Fungi; Naphthols; Octanols; Sesquiterpenes; Sesquiterpenes, Germacrane; Sick Building Syndrome; Solid Phase Extraction; Species Specificity; Temperature; Volatile Organic Compounds | 2012 |